PuraPharm Corporation Limited (HKG:1498)
Hong Kong
· Delayed Price · Currency is HKD 0.4800
-0.0100 (-2.04%)
May 16, 2025, 1:57 PM HKT
PuraPharm Corporation Revenue
In the year 2024, PuraPharm Corporation had annual revenue of 382.09M HKD, down -6.09%. PuraPharm Corporation had revenue of 174.46M in the half year ending December 31, 2024, a decrease of -19.72%.
Revenue
382.09M
Revenue Growth
-6.09%
P/S Ratio
0.50
Revenue / Employee
797.68K
Employees
479
Market Cap
189.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 382.09M | -24.77M | -6.09% |
| Dec 31, 2023 | 406.86M | -41.21M | -9.20% |
| Dec 31, 2022 | 448.07M | -211.52M | -32.07% |
| Dec 31, 2021 | 659.59M | 57.78M | 9.60% |
| Dec 31, 2020 | 601.82M | -94.06M | -13.52% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Alibaba Health Information Technology | 31.39B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |